Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 2 , Pages 109-115 , March 2006

Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: Preliminary results

  • Essam Elsamman, M.S.

      Affiliations

    • Department of Urology, The University of Tokushima School of Medicine, Tokushima, Japan
    • ,
  • Tomoharu Fukumori, M.D., Ph.D.

      Affiliations

    • Department of Urology, The University of Tokushima School of Medicine, Tokushima, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-088-633-7159; fax: +81-088-633-7160
    • ,
  • Ashraf A. Ewis, M.D., Ph.D.

      Affiliations

    • Single-Molecule Bioanalysis Laboratory, National Institute of Advanced Industrial Science and Technology (AIST), Tokushima, Japan
    • ,
  • Nermin Ali, M.S.

      Affiliations

    • Department of Pharmacology, Institute for Genome Research, The University of Tokushima School of Medicine, Tokushima, Japan
    • ,
  • Kazuaki Kajimoto, Ph.D.

      Affiliations

    • Division of Gene Expression, Institute for Genome Research, The University of Tokushima School of Medicine, Tokushima, Japan
    • ,
  • Yasuo Shinohara, Ph.D.

      Affiliations

    • Division of Gene Expression, Institute for Genome Research, The University of Tokushima School of Medicine, Tokushima, Japan
    • ,
  • Mitsuru Ishikawa, Ph.D.

      Affiliations

    • Single-Molecule Bioanalysis Laboratory, National Institute of Advanced Industrial Science and Technology (AIST), Tokushima, Japan
    • ,
  • Masayuki Takahashi, M.D., Ph.D.

      Affiliations

    • Department of Urology, The University of Tokushima School of Medicine, Tokushima, Japan
    • ,
  • Masa-aki Nishitani, M.D., Ph.D.

      Affiliations

    • Department of Urology, The University of Tokushima School of Medicine, Tokushima, Japan
    • ,
  • Yoshinobu Baba, Ph.D.

      Affiliations

    • Single-Molecule Bioanalysis Laboratory, National Institute of Advanced Industrial Science and Technology (AIST), Tokushima, Japan
    • ,
  • Hiro-omi Kanayama, M.D., Ph.D.

      Affiliations

    • Department of Urology, The University of Tokushima School of Medicine, Tokushima, Japan

Received 21 February 2005 ,Revised 23 July 2005 ,Accepted 25 July 2005.

References 

  1. Jemal A , Murray T , Ward E , et al.   Cancer Statistics, 2005 . CA Cancer J Clin . 2005;55:10–30
  2. Al-Sukhun S , Hussain M . Current understanding of the biology of advanced bladder cancer . Cancer . 2003;97:2064–2075
  3. Al-Sukhun S , Hussain M . Molecular biology of transitional cell carcinoma . Crit Rev Oncol Hematol . 2003;47:181–193
  4. Zieger K , Olsen PR , Wolf H , et al.   Long term follow-up of superficial invasive bladder carcinoma with or without concomitant epithelial atypia–Recurrence and progression . Scand J Urol Nephrol . 2002;36:52–59
  5. Burchardt M , Burchardt T , Shabsigh A , et al.   Current concepts in biomarker technology for bladder cancers . Clin Chem . 2000;46:595–605
  6. Stein JP , Lieskovsky G , Cote R , et al.   Radical cystectomy in the treatment of invasive bladder cancer (Long-term results in 1,054 patients) . J Clin Oncol . 2001;19:666–675
  7. Mostofi FK, Davis CJ, Sesterhenn IA . Histological typing of urinary bladder tumors. World Health Organization, International Histological Classification of Tumors. 2nd ed. Berlin: Germany: Springer-Verlag; 1999;
  8. Sobin LH , Fleming ID  Union Internationale Contre le Cancer and the American Joint Committee on Cancer . TNM Classification of Malignant Tumors, fifth edition (1997) . Cancer . 1997;80:1803–1804
  9. Bonham MJ , Danielpour D . Improved purification and yields of RNA by Rneasy . Biotechniques . 1996;21:57–60
  10. Ying-Hao S , Qing Y , Lin-Hui W , et al.   Monitoring gene expression profile changes in bladder transitional cell carcinoma using cDNA microarray . Urol Oncol . 2002;7:207–212
  11. Modlich O , Prisack HB , Pitschk G , et al.   Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder (Use of cDNA array analysis of gene expression profiles) . Clin Cancer Res . 2004;10:3410–3421
  12. Dyrskjot L , Kruhoffer M , Thykjaer T , et al.   Gene expression in the urinary bladder (A common carcinoma in situ gene expression signature exists disregarding histo-pathological classification) . Cancer Res . 2004;64:4040–4048
  13. Mor O , Nativ O , Stein A , et al.   Molecular analysis of transitional cell carcinoma using cDNA microarray . Oncogene . 2003;22:7702–7710
  14. Southgate J , Harnden P , Trejdosiewicz LK . Cytokeratin expression patterns in normal and malignant urothelium (A review of the biological and diagnostic implications) . Histol Histopathol . 1999;14:657–664
  15. Kirkali G , Tuzel E , Guler C , et al.   Significance of tissue laminin P (1) elastase and fibronectin levels in transitional cell carcinoma of the bladder . Eur Urol . 2001;39:292–299
  16. Sachs MD , Rauen KA , Ramamurthy M , et al.   Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer . Urology . 2002;60:531–536
  17. Lewis TS , Shapiro PS , Ahn NG . Signal transduction through MAP kinase cascades . Adv Cancer Res . 1998;74:49–139
  18. Chatterjee SJ , Datar R , Youssefzadeh D , et al.   Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma . J Clin Oncol . 2004;22:1007–1013
  19. Blanes A , Rubio J , Martinez A , et al.   Kinetic profiles by topographic compartments in muscle-invasive transitional cell carcinomas of the bladder (Role of TP53 and NF1 genes) . Am J Clin Pathol . 2002;118:93–100
  20. Nakanishi K , Kawai T , Sato H , et al.   Expression of matrix metalloproteinase-2 (MMP-2) and of membrane-type-1-matrix metalloproteinase (MT1-MMP) in transitional cell carcinoma of the upper urinary tract . Hum Pathol . 2000;31:193–200
  21. Sumi T , Yoshida H , Hyun Y , et al.   Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder . Oncol Rep . 2003;10:345–349
  22. Inoue K , Kamada M , Slaton JW , et al.   The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter . Clin Cancer Res . 2002;8:1863–1870
  23. Zheng HC , Sun JM , Li XH , et al.   Role of PTEN and MMP- 7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma . Pathol Int . 2003;53:659–666
  24. Sumi T , Nakatani T , Yoshida H , et al.   Expression of matrix metalloproteinases 7 and 2 in human renal cell carcinoma . Oncol Rep . 2003;10:567–570
  25. Zeng ZS , Shu WP , Cohen AM , et al.   Matrix metalloproteinase-7 expression in colorectal cancer liver metastases (Evidence for involvement of MMP-7 activation in human cancer metastases) . Clin Cancer Res . 2002;8:144–148
  26. Kireeva ML , MO FE , Yang GP , et al.   Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion . Mol Cell Biol . 1996;16:1326–1334
  27. Tsai MS , Bogart DF , Castaneda JM , et al.   Cyr61 promotes breast tumorigenesis and cancer progression . Oncogene . 2002;21:8178–8185
  28. Zeng ZJ , Yang LY , Ding X , et al.   Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance . World J Gastroenterol . 2004;10:3414–3418
  29. Pilarsky CP , Schmidt U , Eissrich C , et al.   Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer . Prostate . 1998;36:85–91
  30. Tong X , Xie D , O’Kelly J , et al.   Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer . J Biol Chem . 2001;276:47709–47714
  31. Yang CC , Chu KC , Yeh WM . The expression of vascular endothelial growth factor in transitional cell carcinoma of urinary bladder is correlated with cancer progression . Urol Oncol . 2004;22:1–6
  32. Li S , Nomata K , Sawase K , et al.   Prognostic significance of platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in stage pT1 G3 bladder cancer . Int J Urol . 2001;8:478–482
  33. Saito T , Tomita Y , Kawasaki T , et al.   Subsequent activation of mitogen-activated protein kinase after adhesion of transitional cell cancer cells to fibronectin . Urol Int . 2002;69:125–128

PII: S1078-1439(05)00220-6

doi: 10.1016/j.urolonc.2005.07.011

Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 2 , Pages 109-115 , March 2006

Article Tools

* Image Usage & Resolution